Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)

Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)

Abstract The Global Parkinson’s Genetics Program (GP2) will genotype over 150,000 participants from around the world, and integrate genetic and clinical data for use in large-scale analyses to dramatically expand our understanding of the genetic architecture of PD. This report details the workflow f...

Full description

Bibliographic Details
Main Authors: Clodagh Towns, Madeleine Richer, Simona Jasaityte, Eleanor J. Stafford, Julie Joubert, Tarek Antar, Alejandro Martinez-Carrasco, Mary B. Makarious, Bradford Casey, Dan Vitale, Kristin Levine, Hampton Leonard, Caroline B. Pantazis, Laurel A. Screven, Dena G. Hernandez, Claire E. Wegel, Justin Solle, Mike A. Nalls, Cornelis Blauwendraat, Andrew B. Singleton, Manuela M. X. Tan, Hirotaka Iwaki, Huw R. Morris, the Global Parkinson’s Genetics Program (GP2)
Format: Article
Language:English
Published: Nature Portfolio 2023-09-01
Series:npj Parkinson's Disease
Online Access:https://doi.org/10.1038/s41531-023-00533-w

Internet

https://doi.org/10.1038/s41531-023-00533-w

Similar Items